Nicolas Moniotte
Head of Clinical Affairs DNA Script
Seminars
Thursday 1st October 2026
Rethinking What’s Upstream: How Our New Platform is Transforming GMP-Grade DNA Manufacturing
2:00 pm
- Personalized cancer vaccines and next-gen RNA therapeutics demand more complex, faster DNA manufacturing than conventional plasmid fermentation can deliver
- Plasmid fermentation brings biological variability, multi-week lead times, costly changeovers, and fermentation capacity sitting idle between programs, hurting project economics and margin
- ENCODEX turns any sequence into IVT-ready, GMP-grade DNA in 5 days, no cloning, no sequence-dependent failures, no changeover between programs. The result: a flexible, programmable DNA manufacturing infrastructure as therapies it enables, delivering speed and scale without compromising accuracy, quality, or regulatory rigor
